Preliminary application of radioimmunoassay of monoclonal antibody against carbohydrate CA19-9 in the diagnosis and treatment of digestive tract tumors

Liu Xiongbo, Qi Yanchao, Wang Jinghua, Zhao Rongqing, Liu Xiaolan, Zhang Xiaomin, Liu Yunzhen, Huang Jianying

1. Cancer Hospital of Henan Cancer Institute 2. Cancer Hospital of Henan Cancer Institute 3. Cancer Hospital of Henan Cancer Institute 4. Cancer Hospital of Henan Cancer Institute 5. Cancer Hospital of Henan Cancer Institute 6. Cancer Hospital of Henan Cancer Institute 7. Cancer Hospital of Henan Cancer Institute 8. Tianjin Cancer Institute

Abstract: this paper reports the application of American Cenfocor company's anti CA19-9 anti monoclonal antibody solid phase radioimmunoassay kit to test 23 cases of normal people, 68 cases of various benign and malignant digestive tract diseases before treatment, 56 cases of pancreatic cancer after treatment, colon cancer patients serum CA19-9 content, while detecting the content of CEA in serum. The result is that normal people CA19-9

• Album: Medical and Health Technology
• Special Topic: Oncology

Carbohydrate anti-CA19-9 monoclonal... Preliminary application in tumor diagnosis and treatment_Liu Xiongbo.pdf